Orthobiologics company Ossio closed $50 million in credit facility from Horizon Technology Finance and Monroe Capital, according to a Feb. 11 news release.
The deal includes initial $40 million senior credit facility for Ossio, along with an additional $10 million available for future growth. Ossio was founded in 2014 and develops regenerative orthopedic products.
“This partnership combines deep healthcare technology expertise with growth capital,” Brian Verrier, OSSIO’s CEO, said in the release. “Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company’s mission of transforming the orthopedic experience for patients.”
